PROCEPT BioRobotics Corp (PRCT) shareholders
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3050% below fair value
$23.80+0.29 (+1.23%)
Close on Nov 13, 2026Market cap $1.36BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
95.8%
55M of 57M shares
Institutional holders
254
39 new, 36 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
8 buys · 15 sales
Net bought $10.27M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,646,656 | 8.20% | 13G (passive) amendment | Jun 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 3,271,408 | 5.90% | 13G (passive) | Dec 31, 2025 |
| BNP Paribas Asset Management Holding S.A. | 3,094,649 | 5.50% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PRCT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,869,828 | 8.50% | $109.96M | +507,826 | 0.00% |
| T. Rowe Price Investment Management, Inc. | 3,265,704 | 5.70% | $73.74M | −8,090 | 0.05% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,823,849 | 4.93% | $63.76M | −265,529 | 0.06% |
| Vanguard Portfolio Management LLC | 2,526,802 | 4.41% | $57.06M | +105,440 | 0.00% |
| Vanguard Capital Management LLC | 2,460,802 | 4.30% | $55.56M | +61,735 | 0.00% |
| Chicago Capital, LLC | 2,073,237 | 3.62% | $46.81M | −87,350 | 1.13% |
| State Street Corp | 1,617,475 | 2.82% | $36.52M | +87,844 | 0.00% |
| Geode Capital Management, LLC | 1,484,163 | 2.59% | $33.52M | +120,663 | 0.00% |
| FMR LLC | 1,444,878 | 2.52% | $32.63M | −17,026 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 1,332,452 | 2.33% | $30.09M | +726,494 | 0.00% |
| Wellington Management Group Llp | 1,274,004 | 2.22% | $28.77M | +412,399 | 0.00% |
| Federated Hermes, Inc. | 1,253,420 | 2.19% | $28.30M | +1,078,984 | 0.04% |
| Jupiter Topco LLC | 1,103,404 | 1.93% | $24.91M | New | 0.01% |
| Frontier Capital Management Co LLC | 1,091,528 | 1.91% | $24.65M | +481,671 | 0.23% |
| Soleus Capital Management, L.P. | 1,003,000 | 1.75% | $22.65M | +843,000 | 0.78% |
| Champlain Investment Partners, LLC | 981,381 | 1.71% | $22.16M | −154,941 | 0.57% |
| Baillie Gifford & Co | 911,751 | 1.59% | $20.59M | −61,751 | 0.02% |
| Fiera Capital Corp | 774,569 | 1.35% | $17.49M | −193,026 | 0.06% |
| LMR Partners LLP | 721,608 | 1.26% | $16.29M | New | 0.06% |
| William Blair Investment Management, LLC | 709,484 | 1.24% | $16.02M | +285,175 | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 254 | 55M | 95.8% | 39 / 107 | 66 / 36 | 11M | 11M |
| Q1 2026 | 257 | 56M | 97.6% | 47 / 97 | 68 / 46 | 18M | 13M |
| Q4 2025 | 263 | 57M | 98.8% | 64 / 110 | 59 / 39 | 12M | 12M |
| Q3 2025 | 242 | 58M | 100.0% | 37 / 95 | 69 / 62 | 11M | 6M |
| Q2 2025 | 271 | 54M | 93.5% | 34 / 120 | 83 / 40 | 8M | 5M |
| Q1 2025 | 279 | 50M | 88.1% | 51 / 99 | 95 / 51 | 7M | 6M |
| Q4 2024 | 281 | 50M | 87.9% | 66 / 116 | 77 / 31 | 8M | 4M |
| Q3 2024 | 250 | 47M | 81.3% | 73 / 85 | 71 / 23 | 9M | 5M |
| Q2 2024 | 202 | 45M | 79.2% | 55 / 77 | 51 / 13 | 7M | 9M |
| Q1 2024 | 162 | 47M | 81.8% | 31 / 60 | 46 / 13 | 4M | 4M |
| Q4 2023 | 145 | 46M | 80.5% | 31 / 68 | 37 / 12 | 5M | 4M |
| Q3 2023 | 127 | 44M | 77.7% | 22 / 64 | 27 / 14 | 10M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
189 funds held PRCT in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PRCT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,708,164 | 2.98% | $38.57M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,458,690 | 2.55% | $32.94M | 0.04% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1,318,120 | 2.30% | $29.76M | 0.32% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,239,150 | 2.16% | $27.98M | 0.01% | Jun 30, 2026 |
| Janus Henderson Venture Fund | 890,509 | 1.55% | $20.11M | 0.56% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 711,299 | 1.24% | $16.06M | 0.03% | Jun 30, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 695,936 | 1.22% | $15.71M | 0.31% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 652,016 | 1.14% | $14.72M | 0.02% | Jun 30, 2026 |
| Federated Hermes MDT Small Cap Core Fund | 647,169 | 1.13% | $12.05M | 0.54% | Jul 31, 2026 |
| Fidelity Growth Company Fund | 642,617 | 1.12% | $16.92M | 0.02% | May 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 615,254 | 1.07% | $13.89M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 613,609 | 1.07% | $11.43M | 0.03% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 518,604 | 0.91% | $11.71M | 0.08% | Jun 30, 2026 |
| Global X Robotics & Artificial Intelligence ETF | 425,262 | 0.74% | $11.20M | 0.30% | May 31, 2026 |
| Champlain Small Company Fund | 401,000 | 0.70% | $9.05M | 1.09% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Larry L. Wood | President, CEO, Director | 338,103 | 0.59% | Aug 10, 2026 |
| Reza Zadno | President, CEO, Director | 186,829 | 0.33% | May 13, 2025 |
| Pooja Sharma | Chief Strat/Marketing Officer | 106,471 | 0.19% | Nov 6, 2026 |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | 127,737 | 0.22% | Sep 10, 2026 |
| Barry L. Templin | EVP, Chief Technology Officer | 151,283 | 0.26% | Sep 10, 2026 |
| Kevin Waters | EVP, CFO | 180,355 | 0.31% | Sep 10, 2026 |
| Hisham Shiblaq | EVP, Chief Comm. Officer | 83,133 | 0.15% | Jun 6, 2025 |
| Michael Mack | Director | 7,727 | 0.01% | Oct 5, 2026 |
| Mary Garrett | Director | 17,700 | 0.03% | Jun 10, 2026 |
| Elisabeth Sandoval Little | Director | 15,876 | 0.03% | Jun 10, 2026 |
| Antal Rohit Desai | Director | 477,792 | 0.83% | Jun 10, 2026 |
| Frederic H. Moll | Director | 866,474 | 1.51% | Jun 10, 2026 |
| Thomas M. Prescott | Director | 7,211 | 0.01% | Jun 10, 2026 |
| Amy M. Dodrill | Director | 10,941 | 0.02% | Jun 10, 2026 |
| Dan Puckett | Director | 8,791 | 0.02% | Jun 10, 2026 |
| Taylor C. Harris | Director | 137,565 | 0.24% | Jun 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Pooja Sharma Chief Strat/Marketing Officer | Nov 6, 2026 | Sale | −4,710 | $19.71 | $92.85K | 106,471 |
| Michael Mack Director | Oct 2, 2026 | Award | +7,727 | – | – | 7,727 |
| Barry L. Templin EVP, Chief Technology Officer | Sep 9, 2026 | Sale | −373 | $20.95 | $7.81K | 94,826 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Sep 9, 2026 | Sale | −297 | $20.95 | $6.22K | 127,737 |
| Kevin Waters EVP, CFO | Sep 9, 2026 | Sale | −373 | $20.95 | $7.81K | 180,355 |
| Kevin Waters EVP, CFO | Aug 13, 2026 | Award | +29,527 | – | – | 180,728 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Aug 13, 2026 | Award | +22,965 | – | – | 128,034 |
| Barry L. Templin EVP, Chief Technology Officer | Aug 13, 2026 | Award | +26,246 | – | – | 95,199 |
| Pooja Sharma Chief Strat/Marketing Officer | Aug 13, 2026 | Award | +23,622 | – | – | 111,181 |
| Larry L. Wood President, CEO, Director | Aug 7, 2026 | Buy | +23,900 | $20.85 | $498.32K | 23,900 |
| Dan Puckett Director | Jun 9, 2026 | Award | +3,315 | – | – | 8,791 |
| Frederic H. Moll Director | Jun 9, 2026 | Award | +3,315 | – | – | 866,474 |
| Mary Garrett Director | Jun 9, 2026 | Award | +3,315 | – | – | 17,700 |
| Amy M. Dodrill Director | Jun 9, 2026 | Award | +3,315 | – | – | 10,941 |
| Taylor C. Harris Director | Jun 9, 2026 | Award | +3,315 | – | – | 102,491 |
| Elisabeth Sandoval Little Director | Jun 9, 2026 | Award | +3,315 | – | – | 15,876 |
| Antal Rohit Desai Director | Jun 9, 2026 | Award | +3,315 | – | – | 38,467 |
| Thomas M. Prescott Director | Jun 9, 2026 | Award | +3,315 | – | – | 7,211 |
| Kevin Waters EVP, CFO | Jun 8, 2026 | Sale | −357 | $28.48 | $10.17K | 151,201 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Jun 8, 2026 | Sale | −285 | $28.48 | $8.12K | 105,069 |
| Barry L. Templin EVP, Chief Technology Officer | Jun 8, 2026 | Sale | −358 | $28.48 | $10.20K | 68,953 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 19, 2026 | Sale(10b5-1 plan) | −2,332 | $26.15 | $60.98K | 105,354 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 19, 2026 | Sale(10b5-1 plan) | −3,031 | $25.82 | $78.26K | 107,686 |
| Kevin Waters EVP, CFO | Mar 17, 2026 | Sale | −706 | $28.15 | $19.87K | 151,558 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 17, 2026 | Sale | −304 | $28.15 | $8.56K | 110,717 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 10, 2026 | Sale(10b5-1 plan) | −3,098 | $25.60 | $79.31K | 111,166 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 10, 2026 | Sale(10b5-1 plan) | −145 | $26.74 | $3.88K | 111,021 |
| Antal Rohit Desai Director | Mar 9, 2026 | Buy | +53,818 | $24.91 | $1.34M | 424,962 |
| Antal Rohit Desai Director | Mar 9, 2026 | Buy | +1,300 | $25.42 | $33.05K | 426,262 |
| Antal Rohit Desai Director | Mar 9, 2026 | Buy | +43,581 | $24.08 | $1.05M | 371,144 |
| Antal Rohit Desai Director | Mar 6, 2026 | Buy | +106,554 | $23.33 | $2.49M | 273,800 |
| Antal Rohit Desai Director | Mar 6, 2026 | Buy | +53,763 | $24.10 | $1.30M | 327,563 |
| Kevin Waters EVP, CFO | Mar 6, 2026 | Sale | −6,721 | $23.70 | $159.29K | 152,264 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 6, 2026 | Sale | −6,892 | $23.70 | $163.34K | 114,264 |
| Larry L. Wood President, CEO, Director | Mar 5, 2026 | Award | +127,783 | – | – | 313,378 |
| Antal Rohit Desai Director | Mar 5, 2026 | Buy | +24,748 | $26.41 | $653.59K | 167,246 |
| Antal Rohit Desai Director | Mar 5, 2026 | Buy | +142,498 | $25.44 | $3.63M | 142,498 |
| Kevin Waters EVP, CFO | Mar 5, 2026 | Award | +47,462 | – | – | 158,985 |
| Dan Puckett Director | Mar 5, 2026 | Award | +5,476 | – | – | 5,476 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Mar 5, 2026 | Award | +43,811 | – | – | 121,156 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Feb 19, 2026 | Award | +4,872 | – | – | 77,345 |
| Kevin Waters EVP, CFO | Feb 19, 2026 | Award | +3,532 | – | – | 111,523 |
| Larry L. Wood President, CEO, Director | Sep 2, 2025 | Award | +182,392 | – | – | 185,595 |
| Antal Rohit Desai Director | Aug 14, 2025 | Option exercise | +26,749 | $1.33 | $35.58K | 35,152 |
| Alaleh Nouri EVP, CLO, CORP. SEC. | Aug 14, 2025 | Option exercise | +11,000 | $4.52 | $49.72K | 72,473 |
| Frederic H. Moll Director | Aug 13, 2025 | Buy | +20,000 | $39.26 | $785.20K | 863,159 |
| Antal Rohit Desai Director | Jun 12, 2025 | Sale(10b5-1 plan) | −19,951 | $61.28 | $1.22M | 19,412 |
| Antal Rohit Desai Director | Jun 12, 2025 | Sale(10b5-1 plan) | −5,049 | $62.33 | $314.70K | 14,363 |
| Antal Rohit Desai Director | Jun 11, 2025 | Sale(10b5-1 plan) | −7,788 | $62.59 | $487.45K | 56,575 |
| Antal Rohit Desai Director | Jun 11, 2025 | Sale(10b5-1 plan) | −11,495 | $63.47 | $729.59K | 45,080 |
| Antal Rohit Desai Director | Jun 11, 2025 | Sale(10b5-1 plan) | −5,717 | $64.27 | $367.43K | 39,363 |
| Elisabeth Sandoval Little Director | Jun 10, 2025 | Award | +1,538 | – | – | 12,561 |
| Taylor C. Harris Director | Jun 10, 2025 | Award | +1,538 | – | – | 99,176 |
| Mary Garrett Director | Jun 10, 2025 | Award | +1,538 | – | – | 14,385 |
| Frederic H. Moll Director | Jun 10, 2025 | Award | +1,538 | – | – | 843,159 |
| Larry L. Wood Director | Jun 10, 2025 | Award | +1,538 | – | – | 5,968 |
| Amy M. Dodrill Director | Jun 10, 2025 | Award | +1,538 | – | – | 7,626 |
| Antal Rohit Desai Director | Jun 10, 2025 | Sale(10b5-1 plan) | −1,726 | $64.67 | $111.62K | 64,363 |
| Antal Rohit Desai Director | Jun 10, 2025 | Award | +1,538 | – | – | 8,403 |
| Antal Rohit Desai Director | Jun 10, 2025 | Sale(10b5-1 plan) | −18,412 | $64.02 | $1.18M | 66,089 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
14.41%
8M shares short
Days to cover
9.0
At 1M shares a day
Change since last report
+4.8%
From 8M shares
Short volume, 20 days
45.8%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of PROCEPT BioRobotics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 54,244 shares on Sep 4, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Pooja Sharma Officer | Nov 6, 2026 | 4,710 | $92.85K | Nov 6, 2026 | Restricted Stock Vesting |
| Alaleh Nouri Officer | Sep 9, 2026 | 297 | $6.22K | Sep 9, 2026 | Restricted Stock Vesting |
| Barry L. Templin Officer | Sep 9, 2026 | 373 | $7.82K | Sep 9, 2026 | Restricted Stock Vesting |
| Kevin Waters Officer | Sep 9, 2026 | 373 | $7.82K | Sep 9, 2026 | Restricted Stock Vesting |
| Barry L. Templin Officer | Jun 8, 2026 | 358 | $10.20K | Jun 8, 2026 | Restricted Stock Vesting |
| Alaleh Nouri Officer | Jun 8, 2026 | 285 | $8.12K | Jun 8, 2026 | Restricted Stock Vesting |
| Kevin Waters Officer | Jun 8, 2026 | 357 | $10.17K | Jun 8, 2026 | Restricted Stock Vesting |
| Alalah Nouri Officer | Mar 19, 2026 | 5,363 | $140.35K | Mar 19, 2026 | RSU Vest |
| Kevin Waters Officer | Mar 17, 2026 | 706 | $19.88K | Mar 17, 2026 | Restricted Stock Vesting |
| Alaleh Nouri Officer | Mar 17, 2026 | 304 | $8.56K | Mar 17, 2026 | Restricted Stock Vesting |
| Alalah Nouri Officer | Mar 10, 2026 | 3,243 | $81.92K | Mar 10, 2026 | RSU Vest |
| Alaleh Nouri Officer | Mar 6, 2026 | 6,892 | $163.35K | Mar 6, 2026 | Restricted Stock Vesting |
| Kevin Waters Officer | Mar 6, 2026 | 6,721 | $159.30K | Mar 6, 2026 | Restricted Stock Vesting |
| Sham Shiblaq Officer, Director | Jun 6, 2025 | 20,000 | $1.28M | Jun 6, 2025 | Exercise of options under a registered plan |
| 222 Dna Trust Director | Jun 3, 2025 | 150,000 | $8.69M | Jun 3, 2025 | Pre-IPO |
See a number that looks wrong?